Philip P Storey, Zujaja Tauqeer, Yoshihiro Yonekawa, Bozho Todorich, Jeremy D Wolfe, Sumit P Shah, Ankoor R Shah, Takashi Koto, Ashkan M Abbey, Yuki Morizane, Priya Sharma, Edward H Wood, Mio Morizane-Hosokawa, Pooja Pendri, Maitri Pancholy, Shawn Harkey, Karen W Jeng-Miller, Anthony Obeid, Durga S Borkar, Eric Chen, Patrick Williams, Annabelle A Okada, Makoto Inoue, Fumio Shiraga, Akito Hirakata, Chirag P Shah, Jonathan Prenner, Sunir Garg
PURPOSE: To compare the rates of infectious endophthalmitis following intravitreal injection of ranibizumab using prefilled syringes vs conventional preparation. DESIGN: Multicenter retrospective cohort study. METHODS: All eyes receiving intravitreal injection of 0.5 mg ranibizumab for retinal vascular diseases at 10 retina practices across the United States (2016 to 2017) and Japan (2009 to 2017) were included. The total numbers of eyes and injections were determined from billing codes...
March 2019: American Journal of Ophthalmology